AML Archives - Together4Cancer Compass

Patients

HCPs

Home

Categories

Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age.

Post category:Hematologic Cancers
Reading time:2 mins read

This retrospective registry analysis (2017–2021) evaluated 4258 adults with acute leukemia undergoing first allogeneic...

Continue Reading

A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions.

Post category:Hematologic Cancers
Reading time:2 mins read

This review article synthesizes current knowledge on myelodysplastic neoplasms (MDS), emphasizing their biological compl...

Continue Reading

Prospective feasibility study of peripheral blood for MRD detection in acute myeloid leukemia by flow cytometry.

Post category:Hematologic Cancers
Reading time:2 mins read

This study evaluated whether multicolor flow cytometry (MFC)–based measurable residual disease (MRD) assessment in per...

Continue Reading

A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Post category:Hematologic Cancers
Reading time:2 mins read

This publication is a narrative review on the modern role of recombinant interferon‑alpha, particularly ropeginterfero...

Continue Reading

Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide study.

Post category:Hematologic Cancers
Reading time:1 min read

This nationwide retrospective study analyzed 7175 patients with MDS or MDS/MPN who underwent first allogeneic HSCT betwe...

Continue Reading

Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel.

Post category:Hematologic Cancers
Reading time:2 mins read

This publication is a special report presenting consensus guidelines for the diagnosis and management of acute myeloid l...

Continue Reading